G. Nicoletti

发表

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

F. Pappalardo, S. Motta, P. Lollini, 2010, Cancer research.

Cancer esearch rated Systems and Technologies : Mathematical Oncology ilico Modeling and In vivo Efficacy of R cer-Preventive Vaccinations

F. Pappalardo, S. Motta, P. Lollini, 2010 .

C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.

P. Lollini, P. Picci, F. Bertoni, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis

G. Benegiamo, P. Lollini, M. Iezzi, 2015, Breast Cancer Research.

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER‐2/neu transgenic mice

P. Musiani, P. Lollini, W. Muller, 1998, International journal of cancer.

Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA).

P. Lollini, K. Scotlandi, P. Nanni, 1989, Anticancer research.

Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells

P. Lollini, M. Colombo, T. Myers, 2014, Growth factors.

Immunological Prevention of a Multigene Cancer Syndrome

P. Musiani, P. Lollini, G. Forni, 2004, Cancer Research.

B Cell Dependent and γ Transgenic Mice Is IFN-neu in HER-2 / Immunoprevention of Mammary Carcinoma and PierLuigi Lollini

P. Musiani, G. Forni, M. Iezzi, 2004 .

Prevention of HER‐2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12

P. Musiani, P. Lollini, G. Forni, 2003, International journal of cancer.

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER‐2/neu oncogene‐driven animal model system

K. Shin‐ya, B. Seliger, P. Lollini, 2010, Proteomics.

Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus

P. Lollini, M. Iezzi, P. Nanni, 2013, PLoS pathogens.

Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells

M. Attimonelli, P. Lollini, V. Giorgio, 2013, Cancer & Metabolism.

Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases

P. Lollini, P. Nanni, F. Alviano, 2015, Oncotarget.

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy

P. Lollini, P. Nanni, C. De Giovanni, 2021, Cells.

p185neu protein is required for tumor and anchorage‐independent growth, not for cell proliferation of transgenic mammary carcinoma

S. Ménard, P. Musiani, P. Lollini, 2000, International journal of cancer.

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

P. Lollini, D. Santini, M. Arigoni, 2021, Scientific Reports.

Virus-like particle display of HER2 induces potent anti-cancer responses

M. Penichet, T. Theander, P. Lollini, 2018, Oncoimmunology.

Immunoprevention and Immunotherapy of Mammary Carcinoma

P. Lollini, P. Nanni, C. De Giovanni, 2010, The breast journal.

HER/erbB Receptors as Therapeutic Targets of Immunotoxins in Human Rhabdomyosarcoma Cells

L. Polito, A. Bolognesi, P. Lollini, 2002, Journal of immunotherapy.

Interferon-mediated enhancement of metastasis. Are MHC antigens involved?

P. Lollini, P. Nanni, G. Nicoletti, 1987, Clinical & Experimental Metastasis.

Multiple steroid hormone receptors in normal and abnormal human endometrium

S. Grilli, P. Nanni, G. Nicoletti, 2004, Journal of Cancer Research and Clinical Oncology.

Systemic effects of cytokines released by gene‐transduced tumor cells: Marked hyperplasia induced in small bowel by γ‐interferon transfectants through host lymphocytes

P. Lollini, W. Grigioni, P. Nanni, 1995, International journal of cancer.

Expression of HER/erbb family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells

S. Ménard, P. Lollini, K. Scotlandi, 2000, International journal of cancer.

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

P. Lollini, M. Iezzi, P. Nanni, 2012, British Journal of Cancer.

Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.

P. Musiani, P. Lollini, G. Forni, 2000, Cancer research.

Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells

P. Lollini, P. Nanni, C. De Giovanni, 2004, Cancer Research.

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

M. Ferracin, P. Lollini, P. Picci, 2019, Scientific Reports.

In vivo reexpression of H-2 antigens in B16 melanoma cells.

P. Lollini, M. Colombo, P. Nanni, 1985, Experimental and Clinical Immunogenetics.

Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.

P. Musiani, P. Lollini, M. Iezzi, 2003, Cancer research.

Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.

P. Lollini, G. Forni, P. Nanni, 1996, British Journal of Cancer.

Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivatives.

P. Lollini, P. Brambilla, P. Nanni, 1985, British Journal of Cancer.

Characterization of biological tissues using X-ray attenuation data

N. Lanconelli, P. Lollini, G. Baldazzi, 2008, 2008 IEEE Nuclear Science Symposium Conference Record.

TNF Impairs In Vivo and In Vitro Natural Killer (NK) Susceptibility of B16 Melanoma Cells

P. Lollini, L. Frati, A. Santoni, 1992, Scandinavian journal of immunology.

Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis

P. Lollini, P. Nanni, A. Palladini, 2008, Pathology & Oncology Research.

The occurrence of multiple steroid hormone receptors in disease‐free and neoplastic human ovary

S. Grilli, P. Nanni, C. De Giovanni, 1981, Cancer.

TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma

P. Lollini, P. Nanni, G. Nicoletti, 1983, Clinical and Experimental Metastasis.

Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.

P. Lollini, P. Nanni, C. De Giovanni, 2007, Oncology reports.

Immunological and non‐immunological influence of H‐2Kb gene transfection on the metastatic ability of B16 melanoma cells

P. Lollini, P. Tazzari, A. Santoni, 1991, International journal of cancer.

Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.

E. Dejana, P. Lollini, E. Lalli, 1993, British Journal of Cancer.

Modulation by Ifn-Gamma of the Metastatic Ability of Murine, Human, and H-2-Transfected Tumor Cells

P. Lollini, K. Scotlandi, P. Nanni, 1989, Tumori.

Antimetastatic activity of a preventive cancer vaccine.

P. Musiani, P. Lollini, M. Iezzi, 2007, Cancer research.

Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 1993, British Journal of Cancer.

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.

P. Musiani, M. Penichet, P. Lollini, 2009, Human gene therapy.

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4

P. Lollini, P. Nanni, C. De Giovanni, 2009, Molecular Cancer Therapeutics.

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role.

P. Lollini, P. Nanni, C. De Giovanni, 2006, European journal of cancer.

Production of stem cell factor and expression of c‐kit in human rhabdomyosarcoma cells: Lack of autocrine growth modulation

P. Lollini, P. Strippoli, P. Nanni, 1998, International journal of cancer.

Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 1996, Cancer research.

Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.

P. Lollini, M. Colombo, P. Nanni, 1995, British Journal of Cancer.

Antimetastatic activity of a preventive cancer vaccine (Cancer Research (2007) 67, (11037-11044))

P. Musiani, P. Lollini, M. Iezzi, 2007 .

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

P. Lollini, C. García-echeverría, K. Scotlandi, 2010, European journal of cancer.

Induction of a malignant phenotype in BALB/c 3t3 cells by 1,1,2,2-tetrachloroethane.

S. Parodi, A. Colacci, D. Noonan, 1993, International journal of oncology.

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

P. Lollini, M. Colombo, P. Nanni, 2018, Oncoimmunology.

Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.

P. Lollini, P. Picci, A. Bernard, 2006, European journal of cancer.

NVP-BEZ235 as a New Therapeutic Option for Sarcomas

P. Lollini, C. García-echeverría, P. Picci, 2010, Clinical Cancer Research.

Human rhabdomyosarcoma cells in nude mice as a model for metastasis and differentiation.

P. Lollini, K. Scotlandi, P. Nanni, 1989, Invasion & metastasis.

RMZ: a new cell line from a human alveolar rhabdomyosarcoma. In vitro expression of embryonic myosin.

P. Lollini, V. Eusebi, S. Schiaffino, 1986, British Journal of Cancer.

Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.

P. Lollini, K. Scotlandi, P. Nanni, 1989, Cancer research.

Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.

P. Musiani, P. Lollini, A. Modesti, 1993, International journal of cancer.

H‐2Kb AND H‐2Db gene transfections in B16 melanoma differently affect non‐immunological properties relevant to the metastatic process. Involvement of integrin molecules

P. Lollini, A. Santoni, P. Nanni, 1994, International journal of cancer.

High-metastatic clones selectedin vitro from a recent spontaneous BALB/c mammary adenocarcinoma cell line

P. Lollini, V. Eusebi, P. Nanni, 1984, Clinical & Experimental Metastasis.

Expression of interleukin 15 (IL‐15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma

P. Lollini, N. Baldini, A. Santoni, 1997, International journal of cancer.

Preclinical In vivo Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma

C. Nanni, P. Lollini, F. Hofmann, 2007, Clinical Cancer Research.

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

P. Lollini, P. Nanni, C. De Giovanni, 2019, BMC Cancer.

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Ilaria Rossi, 1998, The Journal of experimental medicine.

Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia

M. Gobbi, P. Lollini, S. Grilli, 1982, Cancer.

In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.

P. Lollini, L. Tessarollo, G. Azzarello, 1991, British Journal of Cancer.

Clones with different metastatic capacity and variant selection during metastasis: a problematic relationship.

P. Lollini, P. Nanni, C. De Giovanni, 1986, Journal of the National Cancer Institute.

IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTS

P. Lollini, M. Colombo, P. Nanni, 1983, Journal of immunogenetics.

Dexamethasone modulation of in vitro growth pattern and of lung colonization ability in clones of a metastatic BALB/c mammary carcinoma cell line

P. Lollini, S. Grilli, P. Nanni, 2004, Clinical & Experimental Metastasis.

Biologic Charachterization of Pleural Metastases from Lung Adenocarcinoma: Description of the New DV90 Cell Line

F. Monti, L. Chessa, G. Nicoletti, 1994, Tumori.

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model

P. Lollini, P. Nanni, C. De Giovanni, 2019, Cancers.

The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells.

P. Musiani, P. Lollini, G. Forni, 1998, Human gene therapy.

HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response.

P. Lollini, D. Santini, M. Iezzi, 2017, Oncotarget.

Immunological prevention of spontaneous tumors: a new prospect?

P. Musiani, G. Forni, A. Amici, 2002, Immunology letters.

HER 2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset , vasculature and therapeutic response

P. Lollini, D. Santini, M. Iezzi, 2017 .

Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice

P. Lollini, P. Nanni, A. Palladini, 2013, Oncotarget.

Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells

P. Lollini, P. Picci, N. Baldini, 2002, Cancer Gene Therapy.

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

P. Lollini, M. Arigoni, R. Calogero, 2021, Oncogenesis.

Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET

C. Nanni, S. Fanti, P. Lollini, 2010, Molecular Imaging and Biology.

Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer.

C. Nanni, S. Fanti, P. Lollini, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Multidrug resistance and malignancy in human osteosarcoma.

A. Colacci, P. Picci, F. Bertoni, 1996, Cancer research.

CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin

P. Lollini, M. Colombo, P. Picci, 2014, Clinical Cancer Research.

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.

Annalisa Astolfi, Anna Rocchi, Stefania Meschini, 2010, The Journal of clinical investigation.

CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity

P. Picci, A. Bernard, K. Scotlandi, 2007, Oncogene.

Heterogeneity and clonal interactions in the TS/A murine mammary adenocarcinoma.

P. Lollini, K. Scotlandi, P. Nanni, 1988, Advances in experimental medicine and biology.

Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene

P. Musiani, P. Lollini, G. Forni, 1993 .

New target antigens for cancer immunoprevention.

P. Lollini, P. Nanni, C. De Giovanni, 2005, Current cancer drug targets.

Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET

C. Nanni, D. Rubello, S. Fanti, 2010, Journal of experimental & clinical cancer research : CR.

The simultaneous occurrence of cytoplasmic receptors for various steroid hormones in male breast carcinoma and gynaecomastia.

S. Grilli, P. Nanni, C. De Giovanni, 1980, Journal of steroid biochemistry.

Interleukin 12 gene therapy of MHC-negative murine melanoma metastases.

P. Lollini, M. Colombo, A. Stoppacciaro, 1998, Cancer research.

Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells

M. Attimonelli, P. Lollini, V. Giorgio, 2013, Cancer & metabolism.

A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function.

Giovanni Romeo, Giuseppe Gasparre, Anna Ghelli, 2011, Cancer research.

Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling

P. Lollini, K. Schaefer, P. Picci, 2011, Oncogene.

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.

P. Lollini, F. Hofmann, C. García-echeverría, 2005, Cancer research.

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

C. Nanni, S. Fanti, P. Lollini, 2009, Clinical and Experimental Medicine.

c-kit Receptor E xpression i n E wing's S arcoma: L ack o f Prognostic V alue b ut T herapeutic T argeting O pportunities i n Appropriate C onditions

P. Lollini, P. Picci, F. Bertoni, 2003 .

The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.

P. Lollini, K. Scotlandi, P. Nanni, 2000, The American journal of pathology.

Murine model for skeletal metastases of Ewing's sarcoma

P. Lollini, P. Picci, N. Baldini, 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding.

P. Lollini, G. Zauli, K. Scotlandi, 1989, European journal of cancer & clinical oncology.

CD99 engagement: an effective therapeutic strategy for Ewing tumors.

P. Lollini, P. Picci, N. Baldini, 2000, Cancer research.

Multidrug Resistance and Malignancy in Human Osteosarcoma 1 Katia Scotland !

A. Colacci, F. Bertoni, G. Bacci, 2006 .

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2

M. Penichet, P. Lollini, M. Iezzi, 2014, Breast Cancer Research.

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2001, The Journal of experimental medicine.

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

P. Lollini, P. Picci, P. Nanni, 2014, Oncotarget.

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 2001, Gene.

Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.

P. Lollini, G. D’Orazi, S. Soddu, 1998, British Journal of Cancer.

Molecular and cellular biology of rhabdomyosarcoma.

P. Lollini, P. Nanni, C. De Giovanni, 2009, Future oncology.

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

P. Musiani, P. Lollini, R. Kennedy, 2007, International journal of cancer.

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2005, The American journal of pathology.

Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-γ

P. Musiani, P. Lollini, G. Forni, 2001, Gene Therapy.

Modeling the competition between lung metastases and the immune system using agents

Francesco Pappalardo, Marzio Pennisi, Pierluigi Lollini, 2010, BMC Bioinformatics.

Karyotypic characterization of a new human embryonal rhabdomyosarcoma cell line.

F. Faustinella, P. Nanni, L. Larizza, 1991, Cancer genetics and cytogenetics.

Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2004, Cancer Research.

Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-γ and B Cell Dependent1

P. Musiani, P. Lollini, G. Forni, 2004, The Journal of Immunology.

Immunoprevention of colorectal cancer: a future possibility?

P. Musiani, P. Lollini, G. Forni, 2002, Gastroenterology clinics of North America.

Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.

P. Lollini, N. Baldini, K. Scotlandi, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Inhibition of Lung Colonisation of a Mouse Mammary Carcinoma by Therapeutic Vaccination with Interferon-α Gene-Transduced Tumor Cells

Flavia Frabetti, Filippo Belardelli, Piero Musiani, 1998, Clinical & Experimental Metastasis.

Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.

P. Lollini, P. Nanni, C. De Giovanni, 1992, British Journal of Cancer.

Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor

P. Lollini, M. Iezzi, P. Nanni, 2012, PloS one.

A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

A. Mai, P. Lollini, P. Picci, 2018, Molecular Cancer Therapeutics.

Minor histocompatibility antigens do not enhance BALB/c anti-SV40 TASA response.

P. Lollini, S. Grilli, P. Nanni, 1981, British Journal of Cancer.

Inverse relationship between anti-SV40 TASA and anti-H-2 cytotoxic responses

P. Lollini, S. Grilli, P. Nanni, 2004, Journal of Cancer Research and Clinical Oncology.

T U M O R I G E N I C A N D METASTATIC ABILITY OF MHC A N T I G E N EXPRESSION SV40-TRANSFORMED BALB/c CELL LINES

P. Lollini, K. Scotlandi, P. Nanni, 2007 .

Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells.

P. Lollini, K. Scotlandi, P. Nanni, 1991, Invasion & metastasis.

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

P. Musiani, P. Lollini, M. Iezzi, 2009, Vaccine.

Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.

P. Lollini, E. Lalli, P. Nanni, 1992, British Journal of Cancer.

Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma

P. Lollini, P. Tazzari, K. Scotlandi, 1990, Clinical & Experimental Metastasis.

Development of a K-edge micro CT for the study of tumor angiogenesis in small animals

G. Nicoletti, S. Masetti, A. Margotti, 2006, SPIE Medical Imaging.

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

P. Lollini, P. Nanni, C. De Giovanni, 2009, Proceedings of the National Academy of Sciences.

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.

P. Lollini, P. Picci, N. Baldini, 1998, Cancer research.

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy

P. Lollini, P. Picci, A. Caccuri, 2011, Analytical cellular pathology.

TUMORIGENIC AND METASTATIC ABILITY OF SV40‐TRANSFORMED BALB/c CELL LINES AND MHC ANTIGEN EXPRESSION

P. Lollini, K. Scotlandi, P. Nanni, 1989, Journal of immunogenetics.

Are colony-stimulating factor-producing cells facilitated in the metastatic process?

P. Lollini, P. Nanni, C. De Giovanni, 1987, Anticancer research.

Apc10.1: An ApcMin/+ intestinal cell line with retention of heterozygosity

P. Lollini, P. Nanni, C. De Giovanni, 2004, International journal of cancer.

Expression of transduced carcinoembryonic antigen gene in human rhabdomyosarcoma inhibits metastasis.

P. Lollini, A. Santoni, P. Nanni, 1996, Cancer research.

An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma.

P. Lollini, P. Nanni, C. De Giovanni, 2001, European journal of cancer.

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R

P. Lollini, A. Amici, P. Nanni, 2019, Cancers.

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

P. Lollini, P. Nanni, C. De Giovanni, 2019, BMC Cancer.

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

P. Lollini, P. Nanni, C. De Giovanni, 2011, Vaccine.

Cancer Vaccines Co-Targeting HER 2 / Neu and IGF 1 R

P. Lollini, A. Amici, P. Nanni, 2019 .

Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.

P. Lollini, G. Forni, A. Modica, 1995, Human gene therapy.

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent.

P. Musiani, P. Lollini, G. Forni, 2004, Journal of immunology.

Vaccines and other immunological approaches for cancer immunoprevention.

Federica Cavallo, Patrizia Nanni, Guido Forni, 2011, Current drug targets.

Insulin‐like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma

P. Cohen, P. Picci, K. Scotlandi, 2006, International journal of cancer.

Interferon-mediated modulation of metastasis and MHC antigens.

P. Lollini, K. Scotlandi, P. Nanni, 1988, Advances in experimental medicine and biology.

CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin

P. Lollini, M. Colombo, P. Picci, 2014, Clinical Cancer Research.

A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function.

P. Lollini, Christine Betts, K. Scotlandi, 2011, Cancer research.